Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2020-07-29 Regulatory Filings
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is a short filing (3082 characters) announcing a press release about a preclinical study publication. It includes no financial statements or detailed financial data. The document is primarily an announcement of an event and a press release attachment, not a full financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-07-29 English
4 Filing
Director's Dealing
2020-07-27 English
4 Filing
Director's Dealing
2020-07-27 English
8-K Filing
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or material definitive agreements. The text describes an amendment to a government contract (BARDA Contract) increasing funding and extending the contract period. It also references a press release and states that the amendment will be filed as an exhibit to a future 10-Q report. There are no financial statements or detailed financial data included, only a description of the contract amendment and related disclosures. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain a full financial report or earnings release.
2020-07-27 English
4 Filing
Director's Dealing
2020-07-27 English
4 Filing
Director's Dealing
2020-07-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.